No Data
No Data
Tracking of Hong Kong stock concepts | The Medical Insurance Bureau has announced the new medical insurance catalog. Institutions believe that the golden opportunity to increase the allocation of the pharmaceutical sector has already opened (including con
The National Medical Insurance Bureau has conducted preliminary reviews on 440 pharmaceuticals for this year's medical insurance catalog, which is an increase from last year.
Fosun Pharma (600196.SH) does not involve in real estate development business.
Fosun Pharma (600196.SH) stated on the interactive platform on August 8 that the company is not involved in real estate development business. The company is guided by innovation and internationalization, with business covering pharmaceuticals, medical instruments, medical diagnostics, and medical health services, and also covers the pharmaceutical commerce field through its stake in Sinopharm.
Buy Fosun Pharma (02196) in advance! The net purchase of funds from the Hong Kong stock connect has exceeded 0.166 billion yuan for nearly 30 trading days.
With the support of southbound funds, Fosun Pharma has entered the top 20 in the latest shareholding ratio ranking of the Hong Kong Stock Connect.
Shanghai Fosun Pharmaceutical Approves Repurchase, Cancellation of Over 1 Million Restricted Shares
Shanghai Fosun Pharma Announces Share Cancellation
Fosun Pharma (02196) has repurchased and cancelled a total of 1.0722 million shares of A restricted stocks that have been granted but not yet released from restriction.
Fosun Pharma (02196) announced that it will repurchase and cancel a total of 1.0722 million shares that have been granted but have not yet been released from restriction...
No Data